Julia Gilhodes

2.6k total citations
38 papers, 1.2k citations indexed

About

Julia Gilhodes is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Julia Gilhodes has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Genetics. Recurrent topics in Julia Gilhodes's work include Glioma Diagnosis and Treatment (7 papers), Cancer Cells and Metastasis (4 papers) and Immunotherapy and Immune Responses (4 papers). Julia Gilhodes is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Cancer Cells and Metastasis (4 papers) and Immunotherapy and Immune Responses (4 papers). Julia Gilhodes collaborates with scholars based in France, United Kingdom and United States. Julia Gilhodes's co-authors include Thomas Filleron, Nicolás Meyer, Bruno Ségui, Nathalie Andrieu‐Abadie, Thierry Levade, Céline Colacios, Anne Montfort, Caroline Imbert, Philippe Rochaix and Florie Bertrand and has published in prestigious journals such as Nature Communications, Blood and Analytical Chemistry.

In The Last Decade

Julia Gilhodes

38 papers receiving 1.2k citations

Peers

Julia Gilhodes
Amy Ziober United States
Andrew J. Tsung United States
Yvonne T.M. Tsang United States
Kacper Jankowski United States
Julia Gilhodes
Citations per year, relative to Julia Gilhodes Julia Gilhodes (= 1×) peers Tsuyoshi Hata

Countries citing papers authored by Julia Gilhodes

Since Specialization
Citations

This map shows the geographic impact of Julia Gilhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Gilhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Gilhodes more than expected).

Fields of papers citing papers by Julia Gilhodes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Gilhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Gilhodes. The network helps show where Julia Gilhodes may publish in the future.

Co-authorship network of co-authors of Julia Gilhodes

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Gilhodes. A scholar is included among the top collaborators of Julia Gilhodes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Gilhodes. Julia Gilhodes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilhodes, Julia, Bastien Cabarrou, Thomas Filleron, et al.. (2023). Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients. International Journal of Molecular Sciences. 24(18). 14348–14348. 1 indexed citations
2.
Gilhodes, Julia, Bastien Cabarrou, Caroline Dehais, et al.. (2023). A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas. Cancers. 15(12). 3067–3067. 1 indexed citations
3.
Tensaouti, Fatima, Julia Gilhodes, Bastien Cabarrou, et al.. (2023). Pseudoprogression in GBM versus true progression in patients with glioblastoma: A multiapproach analysis. Radiotherapy and Oncology. 181. 109486–109486. 8 indexed citations
4.
Guérard, Adrien, Victor Laurent, Gaëlle Fromont, et al.. (2021). The Chemokine Receptor CCR3 Is Potentially Involved in the Homing of Prostate Cancer Cells to Bone: Implication of Bone-Marrow Adipocytes. International Journal of Molecular Sciences. 22(4). 1994–1994. 19 indexed citations
6.
Herviou, Pauline, Morgane Le Bras, Corinne Hiéblot, et al.. (2020). hnRNP H/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma. Nature Communications. 11(1). 2661–2661. 75 indexed citations
7.
Gal, Jocelyn, Caroline Bailleux, David Chardin, et al.. (2020). Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer. Computational and Structural Biotechnology Journal. 18. 1509–1524. 22 indexed citations
8.
Bergoglio, Valérie, Yea‐Lih Lin, Marie‐Jeanne Pillaire, et al.. (2019). Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner. Nature Communications. 10(1). 910–910. 96 indexed citations
9.
Rouquette, Isabelle, Julia Gilhodes, M.V. Bluthgen, et al.. (2019). Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1. Biomarker Research. 7(1). 28–28. 32 indexed citations
10.
Garandeau, David, J. C. Leclerc, Caroline Imbert, et al.. (2018). Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas. Molecular Cancer Therapeutics. 18(2). 289–300. 26 indexed citations
11.
Malric, Laure, Sylvie Monferran, Caroline Delmas, et al.. (2018). Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells. Molecular Cancer Research. 17(2). 384–397. 28 indexed citations
12.
Gui, Philippe, Florence Dalenc, Camille Franchet, et al.. (2018). The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy. Cancer Immunology Research. 6(11). 1337–1351. 28 indexed citations
13.
Keller, Laura, Nicolas Guibert, Alfredo G. Casanova, et al.. (2018). Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy. Acta Dermato Venereologica. 99(2). 206–210. 23 indexed citations
14.
Grgurević, Srđana, Alice Bradbury, Julia Gilhodes, et al.. (2018). DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 status. Haematologica. 103(6). 1038–1046. 2 indexed citations
15.
Kowalski‐Chauvel, Aline, A. Modesto, Valérie Gouazé‐Andersson, et al.. (2018). Alpha-6 integrin promotes radioresistance of glioblastoma by modulating DNA damage response and the transcription factor Zeb1. Cell Death and Disease. 9(9). 872–872. 33 indexed citations
16.
Andrieu, Guillaume P., Adeline Ledoux, Julia Gilhodes, et al.. (2017). Sphingosine 1-phosphate signaling through its receptor S1P 5 promotes chromosome segregation and mitotic progression. Science Signaling. 10(472). 31 indexed citations
17.
Bertrand, Florie, Anne Montfort, Elie Marcheteau, et al.. (2017). TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma. Nature Communications. 8(1). 2256–2256. 281 indexed citations
18.
Filleron, Thomas, Léonor Chaltiel, Eva Jouve, et al.. (2017). Les nomogrammes dans la pratique clinique : méthodologie, limites et intérêts. Bulletin du Cancer. 105(1). 15–24. 4 indexed citations
19.
Filleron, Thomas, Julia Gilhodes, Alain Duhamel, et al.. (2016). Statistical controversies in clinical research: should schedules of tumor size assessments be changed?. Annals of Oncology. 27(11). 1981–1987. 2 indexed citations
20.
Filleron, Thomas, Julia Gilhodes, Jean‐Pierre Delord, & Bastien Cabarrou. (2016). Analyse en sous-groupes et Forest Plot : limites et intérêts. Bulletin du Cancer. 104(1). 92–100. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026